By The Hill |
February 28, 2020
Two top advisers to President Trump on Wednesday discussed with GOP senators the need for Republicans to lower drug prices and act on health care costs ahead of the election, according to people familiar with the meeting.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders.
One of the most important elements of a company’s success is also one of the least tangible —culture.